Abacus dx appointed exclusive distributor for EuGeni in Australia, New Zealand and the Pacific Islands
We are pleased to have signed a distribution agreement with AnteoTech for their EuGeni platform.
We are pleased to have signed a distribution agreement with AnteoTech for their EuGeni platform.
Products are for professional/laboratory use only.
In the light of the rapidly developing COVID-19 pandemic, we would like to provide the following information about the steps Abacus dx has taken in response to the virus outbreak:
Products are for professional/laboratory use only.
Abacus ALS & Diagnostic Solutions are now Abacus dx
Brisbane, November 21, 2017, Abacus ALS Pty Ltd (Abacus ALS) and Diagnostic Solutions Pty Ltd (Diagnostic Solutions) today announced
Products are for professional/laboratory use only.
In recent times the shareholders of Abacus ALS have been exploring options to transition away from the current shareholding of the business. We are pleased to announce that Diploma PLC has acquired Abacus ALS, and the company will be included in the Diploma Healthcare Group.
Products are for professional/laboratory use only.
Six months after commencing our “Walking for Wellness” challenge, Abacus ALS staff have recently reached our milestone of walking over 3,500 kilometres to raise money for the Paraplegic Benefit Fund (PBF). We started the challenge back in July 2016 with the aim to help our staff increase their wellness, through being more active, whilst also raising money for this worthy cause.
Products are for professional/laboratory use only.
Abacus ALS staff recently took to the streets of Brisbane to participate in the MS Moonlight Walk and help in the fight against Multiple Sclerosis.
Products are for professional/laboratory use only.
Abacus ALS has recently embarked on our Walking for Wellness campaign which is designed to encourage our staff to be more active and to raise money for the Paraplegic Benefit Fund.
Products are for professional/laboratory use only.
Abacus ALS has been improving the healthcare outcomes for millions of Australians and New Zealanders for over 50 years.
Products are for professional/laboratory use only.
Abacus ALS, the Brisbane based distributor of pathology and research laboratory instruments and consumables has announced that Shayne Christensen has been appointed Chief Executive Officer (CEO), effective January 1st 2013.